Unknown

Dataset Information

Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.


ABSTRACT:

Objective

The primary objective of this study was to examine the levels of serum EZH2 in patients diagnosed with bladder cancer, and subsequently evaluate its potential as a biomarker for both the diagnosis and prognosis of bladder cancer.

Methods

Blood samples were obtained from 115 bladder cancer patients and 115 healthy persons. We measured the EZH2 concentrations in the serum of these subjects via enzyme-linked immunosorbent assay (ELISA). To assess the diagnostic performance of serum EZH2 in detecting bladder cancer, we plotted receiver operating characteristic (ROC) curves and calculated their corresponding area under the curve (AUC). We also used the Cox regression model and log-rank test to investigate the correlation between EZH2 levels and clinicopathological chara

SUBMITTER: Li F 

PROVIDER: S-EPMC10927824 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature